NeuroMetrix, Inc. (NasdaqGM: NURO)
Health Care · Health Care Equipment & Supplies · US
$—
— today · — 1Y
NeuroMetrix, Inc. (NasdaqGM: NURO) operates in the Health Care Equipment & Supplies industry within the Health Care sector.
Tweenvest scores NeuroMetrix, Inc. across four factors: quality 38/100, value 68/100, growth 0/100. Its strongest factor is value.
NURO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $3.03M
- P/E
- —
- EPS
- -3.96
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 13
- Next earnings
- —
About NeuroMetrix, Inc.
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
- ISIN
- US6412558073
- Founded
- 1996
- Listed since
- Jul 22, 2004
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CVR Medical Corp.OTCPK: CRRV.F | $132.00 | $— | — |
| Cognetivity Neurosciences Ltd.OTCPK: CGNS.F | $94.00 | $— | — |
| IMRIS Inc.OTCPK: IMRS.Q | $63.00 | $0.00 | — |
| BIOLASE, Inc.OTCPK: BIOL.Q | $37.00 | $— | — |
| Lombard Medical, Inc.OTCPK: EVAR.F | $28.00 | $— | — |
| Imagin Medical Inc.OTCPK: IMEX.F | $11.00 | $— | — |
| STRATA Skin Sciences, Inc.OTCPK: SSKN | $6.00 | $0.00 | -99.98% |
| DIH Holding US, Inc.OTCPK: DHAI | $2.00 | $0.00 | — |
Figures last refreshed Oct 4, 2026.